XAGE (Longevity Health Holdings Inc) Net Sales Margin

Carmell Therapeutics Corporation - graphic logo of issuer XAGE

Longevity Health Holdings (XAGE) is scaling plasma gel sales via contract manufacturing while management finalizes post-merger integration. The net profit margin demonstrates the current resilience of the business, where the 0.00 parameter determines the metric's magnitude. Consequently, Longevity Health Holdings (XAGE) is implementing a scientific approach to rejuvenation by creating regenerative drugs based on the body's own proteins.

XAGE: carmellcosmetics.com Company Net Profitability 03/11/2025 - 09/27/2025

Longevity Health Holdings Inc (XAGE) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Summary company analytics:Carmell Corp - XAGE
Finished products of Carmell Therapeutics Corporation

To identify the fundamental drivers of stability for Longevity Health Holdings (XAGE), analyzing net income relative to revenue is key. This metric determines the portion of income remaining after covering all expenses. The trend in net margin for trading and production activities visualizes the current operational efficiency of the business. For Longevity Health Holdings, this indicator is critical due to the high marketing costs associated with plasma product lines. Controlling profitability allows for an assessment of the company's resilience amid minimal capital reserves.

Analysis of competing companies

HCA: Net Sales Margin|Tenet Healthcare Corporation - Net Profit Rate|Return on Sales by Net Profit FMS|SOLV (Solventum Corporation) - Company Net Profitability|Net Margin encompasshealth.com (EHC)|Net Margin UHS (Universal Health Services Corp)|Net Sales Margin DVA (DaVita HealthCare Partners)|RDNT: Net Return on Sales|OPCH - Net Margin|SGRY - Net Sales Margin|PINC: Net Sales Margin|EYE - Company Sales Margin|Return on Sales by Net Profit PGNY|ARDT (Ardent Health Partners) - Company Net Profitability|Net Margin Select Medical Corp (SEM)|Company Net Profitability ASTH|Net Sales Margin MD (Pediatrix Medical Group, Inc.)|Net Profit Rate USPH|PNTG - Net Margin|Net Profit Rate ORGO (Organogenesis Holdings Inc.)|NUTX: Net Sales Margin|AUNA: Company Net Profitability|Return on Sales by Net Profit SBC|EOLS: Net Profit Rate|Return on Sales by Net Profit CYH (Community Health Corp)|Company Sales Margin The Beauty Health Company|MediWound - Return on Sales by Net Profit|Net Sales Margin biote Corp. BTMD|JYNT: Return on Sales by Net Profit|DocGo Inc. (DCGO) - Return on Sales by Net Profit|Net Return on Sales P3 Health Partners|Return on Sales by Net Profit Gain Therapeutics|EUDA (euda.com) - Net Sales Margin|BMGL - Net Profitability Margin|Net Sales Margin CLGN|Cuprina Holdings - Net Return on Sales|Net Sales Margin CCM (Concord Medical Services Holdings)|Net Sales Margin American Shared Hospital Services Inc AMS|MRM - Net Margin|Avalon GloboCare Corp. - Company Net Profitability|DHAI: Net Sales Margin|NIVF (NewGenIvf Group Limited) - Net Margin|ATIP (ATI Physical Therapy Inc.) - Net Sales Margin|Net Sales Margin CareMax Inc.|Net Margin Kindly MD Inc (KDLY)|Return on Sales by Net Profit ModivCare Corp MODV|Novo Integrated - Return on Sales by Net Profit|Company Net Profitability SSY (SunLink Health Systems)|BACK - Net Margin